KB Financial Partners’s Biogen BIIB Stock Holding History

KB Financial Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$31K	Buy	121 +62	+105%	+$16.6K	0.01%	303
2023 Q2	$17K	Sell	59 -1,742	-97%	-$519K	﹤0.01%	365
2023 Q1	$501K	Sell	1,801 -15	-0.8%	-$4.15K	0.15%	90
2022 Q4	$503K	Sell	1,816 -206	-10%	-$58.2K	0.17%	80
2022 Q3	$540K	Buy	2,022 +345	+21%	+$73.3K	0.19%	68
2022 Q2	$342K	Sell	1,677 -1,259	-43%	-$257K	0.12%	109
2022 Q1	$618K	Buy	2,936 +463	+19%	+$101K	0.17%	52
2021 Q4	$593K	Buy	2,473 +858	+53%	+$221K	0.17%	54
2021 Q3	$457K	Buy	1,615 +153	+10%	+$50.1K	0.17%	71
2021 Q2	$506K	Buy	1,462 +1,457	+29,140%	+$441K	0.19%	53
2021 Q1	$1K	Buy	+5	New	+$1.35K	﹤0.01%	608

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

KB Financial Partners's BIIB Position: Q3 2023 in Review

KB Financial Partners increased its Biogen (BIIB) stake by 105% in Q3 2023, buying an estimated $16.6K and bringing the position to 121 shares worth $31K. The position accounts for 0.01% of the portfolio, ranked #303.

KB Financial Partners first reported a position in BIIB in Q1 2021 and has held it in 11 quarters since. The position peaked at $618K in Q1 2022. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

KB Financial Partners held 121 shares of Biogen worth $31K as of Q3 2023.
KB Financial Partners bought 62 Biogen shares in Q3 2023, an estimated $16.6K.
Biogen made up 0.01% of KB Financial Partners's portfolio in Q3 2023, its #303 holding.
KB Financial Partners first reported a position in Biogen in Q1 2021 and has held it in 11 quarters since.
KB Financial Partners's Biogen position peaked at $618K in Q1 2022.
965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.